18.11: Hemispherx presentasjon av Ampligen og XMRV
Hentet fra XMRV Global actions Facebookside:
«My name is Wayne Pambianchi and my group advises Hemispherx…. My group works very closely with the management team at HEB….One of Hemispherx’s key products is Ampligen and it’s targeted for use with a disease called Chronic Fatigue Syndrome. CFS seems to have a viral etiology and late last year, just about a year ago there was an association made between a mouse murine virus now called XMRV, and CFS. A lot has been published and presented on the relationship between XMRV and CFS, and the presence of XMRV in the blood supply. But more importantly Hemispherx has since last October been working to analyze samples that it retained from its pivotal 516 study, so-called 516 study, with respect to HMRV antibodies that those patients developed, and their response to Ampligen. And I’ll show you a bar graph which represents some minimum results of this work which I think tends to support the relationship between XMRV and CFS and more importantly between XMRV and the patients’ response to Ampligen.»
Les hele presentasjonen HER
Les den på norsk med Google Translater HER
Jeg syntes dette var komplisert og vanskelig å fult ut forstå, så er veldig takknemlig for en enkel oppsummering fra noen som har bedre forståelse av dette.